We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$575M
AUM Growth
+$58.8M
Cap. Flow
+$74.4M
Cap. Flow %
12.93%
Top 10 Hldgs %
36.71%
Holding
556
New
356
Increased
46
Reduced
31
Closed
94

Sector Composition

Rank Sector Weight
1 Healthcare 17.49%
2 Technology 14.77%
3 Financials 8.87%
4 Industrials 5.4%
5 Communication Services 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEM icon
276
Cullinan Oncology
CGEM
$1.07B
$212K 0.04%
+12,164
New +$259K
BCAB icon
277
BioAtla
BCAB
$5.86M
$212K 0.04%
+3,088
New +$367K
NGS icon
278
Natural Gas Services Group
NGS
$460M
$210K 0.04%
+10,446
New +$229K
MAMA icon
279
Mama's Creations
MAMA
$830M
$210K 0.04%
+31,164
New +$190K
BVS icon
280
Bioventus
BVS
$895M
$209K 0.04%
+36,370
New +$200K
ENVX icon
281
Enovix
ENVX
$866M
$207K 0.04%
+15,291
New +$128K
AMLX icon
282
Amylyx Pharmaceuticals
AMLX
$2.17B
$207K 0.04%
+108,862
New +$211K
BMRN icon
283
BioMarin Pharmaceuticals
BMRN
$12B
$206K 0.04%
+2,504
New +$208K
NPWR icon
284
NET Power
NPWR
$126M
$204K 0.04%
+20,748
New +$220K
INO icon
285
Inovio Pharmaceuticals
INO
$84.7M
$201K 0.04%
+24,916
New +$262K
TMO icon
286
Thermo Fisher Scientific
TMO
$214B
$201K 0.04%
+364
New +$209K
BRBS icon
287
Blue Ridge Bankshares
BRBS
$322M
$201K 0.03%
76,900
SPRY icon
288
ARS Pharmaceuticals
SPRY
$563M
$199K 0.03%
+23,435
New +$208K
ACRS icon
289
Aclaris Therapeutics
ACRS
$744M
$196K 0.03%
+177,909
New +$209K
IE icon
290
Ivanhoe Electric
IE
$1.44B
$191K 0.03%
+20,353
New +$216K
AQST icon
291
Aquestive Therapeutics
AQST
$472M
$188K 0.03%
+72,177
New +$241K
TE
292
T1 Energy
TE
$1.16B
$187K 0.03%
+110,002
New +$210K
SANA icon
293
Sana Biotechnology
SANA
$916M
$187K 0.03%
+34,181
New +$272K
MITT
294
TPG Mortgage Investment Trust
MITT
$230M
$186K 0.03%
+28,082
New +$179K
PWP icon
295
Perella Weinberg Partners
PWP
$1.18B
$181K 0.03%
+11,138
New +$168K
VIGL
296
DELISTED
Vigil Neuroscience
VIGL
$180K 0.03%
+44,893
New +$154K
VRDN icon
297
Viridian Therapeutics
VRDN
$2.15B
$179K 0.03%
+13,794
New +$191K
MVF
298
DELISTED
BlackRock MuniVest Fund
MVF
$179K 0.03%
+25,000
New +$175K
INBX icon
299
Inhibrx
INBX
$1.17B
$176K 0.03%
+12,445
New +$194K
ASA
300
ASA Gold and Precious Metals
ASA
$941M
$175K 0.03%
+10,000
New +$176K

Similar funds

Alpine Global Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpine Global Management held 556 positions worth $575M, up 11% from $516M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Alpine Global Management deployed $74.4M of net new capital in Q2 2024, opening 356 new positions and adding to 46 existing holdings. Its largest new stake was Strategy Inc: 192,280 shares worth $26.5M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Robinhood, an estimated $19.6M trimmed.

  • Alpine Global Management's largest Q2 2024 buy was Strategy Inc: 192,280 shares worth $26.5M.
  • Alpine Global Management added most to Archer Aviation in Q2 2024, an estimated $6.74M increase.
  • Alpine Global Management's biggest Q2 2024 reduction was Robinhood, cutting an estimated $19.6M.
  • Alpine Global Management fully exited Agiliti Inc in Q2 2024, selling an estimated $26.4M.
  • Alpine Global Management's ten largest holdings make up 37% of its $575M portfolio in Q2 2024.
  • Alpine Global Management opened 356 new positions and closed 94 in Q2 2024.
  • Alpine Global Management's portfolio value rose 11% quarter-over-quarter to $575M.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.